Zelira Therapeutics Limited (FRA:G1G)

Zelira Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 26, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	2	3	2	10	6	32
Market Cap Growth	-64.15%	47.71%	-81.06%	70.61%	-81.08%	1.10%
Enterprise Value	4	7	3	11	2	27
Last Close Price	0.17	0.23	0.16	0.82	0.63	3.85
PS Ratio	6045.15	7979.80	33.46	56.90	6.03	77.16
PB Ratio	-0.92	-1.22	-0.76	0.54	0.26	1.35
P/TBV Ratio	-	-	-	70.09	2.66	8.59
EV/Sales Ratio	-	18174.22	54.68	58.87	1.88	64.93
Debt / Equity Ratio	-0.50	-0.50	-1.43	0.01	0.01	0.02
Asset Turnover	0	0	0.01	0.01	0.04	0.02
Inventory Turnover	0.93	0.93	0.24	0.36	0.67	-
Quick Ratio	0.01	0.01	0.41	0.08	1.85	4.68
Current Ratio	0.11	0.11	0.60	0.94	3.12	5.66
Return on Equity (ROE)	-	-	-266.82%	-18.60%	-33.77%	-23.62%
Return on Assets (ROA)	-83.30%	-83.30%	-18.87%	-12.51%	-21.42%	-15.60%
Return on Capital (ROIC)	-	-	-21.73%	-13.10%	-22.14%	-15.94%
Return on Capital Employed (ROCE)	100.70%	100.70%	308.80%	-22.40%	-36.60%	-24.50%
Earnings Yield	-91.54%	-69.30%	-1150.98%	-32.53%	-128.58%	-16.70%
FCF Yield	-	-93.74%	-138.13%	-42.31%	-101.48%	-16.84%
Buyback Yield / Dilution	-1.20%	-1.20%	-12.70%	-25.19%	-21.25%	-36.81%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.